Medpace Holdings, Inc. MEDP Metabolic — Total Revenue
Other product segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Medpace Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
The official record: Medpace Holdings, Inc.’s 10-Q, filed April 23, 2026, on SEC EDGAR. View the filing →
Ask your AI about Medpace Holdings, Inc.'s metabolic — total revenue.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Medpace Holdings, Inc.'s metabolic — total revenue?
- Medpace Holdings, Inc. (MEDP) reported metabolic — total revenue of $201.24M in Q1 2026.
- How has Medpace Holdings, Inc.'s metabolic — total revenue changed year-over-year?
- Medpace Holdings, Inc.'s metabolic — total revenue increased by 18.0% year-over-year, from $170.48M to $201.24M.
- What is the long-term trend for Medpace Holdings, Inc.'s metabolic — total revenue?
- Over 4 years (2021 to 2025), Medpace Holdings, Inc.'s metabolic — total revenue has grown at a 19.8% compound annual growth rate (CAGR), from $362.85M to $747.59M.
- What does metabolic — total revenue mean?
- The total revenue earned from providing clinical trial and development services for metabolic disease research.
- How do you interpret metabolic — total revenue?
- An increase indicates growing demand for the company's specialized metabolic research services and successful project execution, while a decrease may signal reduced client spending or increased competition in this therapeutic area.
- How does metabolic — total revenue compare across companies?
- Peers in the contract research organization industry typically report revenue by therapeutic area, allowing for comparison of market penetration and specialization depth in high-growth clinical fields.